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Abstract 
Introduction: The Girdlestone resection arthroplasty (GRA) is a salvage procedure for a recurrent or 
persistent prosthetic joint infection of the hip. This procedure negatively impacts the functional outcome 
and presumably also diminishes health status (HS) and quality of life (QOL). However, studies 
investigating the QOL after GRA are lacking. This cross-sectional study compares patients with a 
Girdlestone situation after an infected total hip prosthesis with a normative population with regard to HS 
and QOL.  
Methods: Patients with a permanent GRA were suitable to be enrolled in the study. Subjects completed 
the World Health Organization Quality of life (WHOQOL-BREF) and the EuroQol 5 dimension 3 level 
version (EQ-5D-3L). Scores were compared with data from the normal population, from patients with a 
lower limb amputations and data from patients with a myocardial infarction.  
Results: Sixty-three patients who underwent GRA between January 2000 and March 2017 completed 
the questionnaire. The median time between the GRA and competing the questionnaire was 48 months 
(4 –436). All WHOQOL-BREF domain scores were significantly lower in GRA patients compared to the 
normative data (p<0.001), patients with myocardial infarction or lower limb amputation. EQ-5D-3L 
results showed that HS was significantly impaired in GRA patients when compared to normative data 
(p<0.001) and also impaired when compared to data from lower limb amputations and myocardial 
infarctions.  
Conclusion: HS and QOL scores in patients with a permanent Girdlestone situation after an infected hip 
prosthesis are significantly lower than Dutch normative scores. Patients with a permanent Girdlestone 
situation scored even lower on HS than patients with a lower limb amputation or a myocardial infarction. 
Key words: Girdlestone, hip resection arthroplasty, quality of life, health status, hip 
Introduction 
Total hip replacement is one of the fastest 
growing orthopaedic procedures worldwide (1, 2). 
One of the leading causes for hip arthroplasty failure 
leading to Girdlestone Resection Arthroplasty (GRA) 
is a prosthetic joint infection (PJI) (3). PJI after total hip 
replacement is an increasing and severe complication 
(2, 4, 5). GRA is defined as the removal of the hip 
prosthesis without a prosthetic replacement. The 
main objectives of GRA are to cure of infection and 
pain relief (6, 7). In most cases, GRA is part of the 
two-stage revision arthroplasty. In some cases of an 
infected total hip prosthesis with recurrent infection 
after reimplantation or no further reconstruction 
options, a GRA is considered as a last resort 
procedure (6). The situation that is created after GRA 
is termed the Girdlestone situation. The Girdlestone 
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situation can result in a permanent clinical situation 
when 1) bone quality or soft tissue coverage is not 
strong enough to insert a new prosthesis, 2) the 
infection persists, or 3) when patients are unfit for 
surgery due to multiple comorbidities (8). Functional 
outcome after GRA is often impaired due to limb 
shortening, hip instability, pseudo arthrosis, and the 
inevitable need for a walking aid (9, 10). Two studies 
reviewed GRA after PJI and concluded that despite 
infection elimination and pain relief, more than 80 
percent of the patients become functionally 
dependent because of their disabilities (10, 11). In the 
current literature, studies focusing on health status 
(HS) after GRA are scarce and remain inconclusive (7, 
12). Moreover, studies focussing on quality of life 
(QOL) in patients after GRA are lacking. Studies on 
patient-reported outcomes measurements are 
important to evaluate the true impact of GRA in 
patients (13).  
In this study, we will evaluate HS and QOL 
scores in patients with a Girdlestone situation after 
PJI. Furthermore, these results will be compared with 
normative data from a Dutch control population. In 
order to place the Girdlestone situation in a 
perspective of disease severity, we will also compare 
the scores obtained in the GRA population with data 
on HS in patients with a lower limb amputation and a 
myocardial infarction. Lower limb amputation was 
chosen because the patient loses (at least partly) a 
lower extremity function (hip/knee), which is 
comparable to GRA. Therefore, these groups may face 
similar consequences on HS and QOL. Myocardial 
infarction was chosen to bring the results in 
comparison to a medical perspective and because 
myocardial infarction is one of the most common 
diseases with a big impact on HS and QOL (14-17).  
Methods  
Study design and setting 
A cross-sectional study was conducted between 
April and August 2017 from the Departments of 
Orthopaedics of the Elisabeth-Tweesteden Hospital in 
Tilburg and Waalwijk, the Erasmus MC, University 
Medical Centre in Rotterdam and the Amphia 
Hospital in Breda and Oosterhout. Additional 
patients were acquired through the Dutch Girdlestone 
Patient Association. This study was approved by the 
Noord-Brabant medical ethical committee 
(NW2017-17).  
Participants and procedure 
Patients were included when they underwent 
GRA between January 2000 and March 2017 and were 
18 years of age or older. There was no upper age limit. 
All patients currently have a permanent Girdlestone 
situation. The definition that was used for a 
permanent Girdlestone situation is to have had a 
Girdlestone situation for ≥4 months. This timeframe 
was chosen because the average prosthetic-free 
interval for the second stage revision is between 6-12 
weeks (18). 
Subjects were not eligible if they 1) received 
another indication for GRA than PJI (cerebral palsy, 
periprosthetic fracture, pathologic fracture, prosthetic 
loosening and hip dislocations), 2) had undergone a 
reimplantation at the time of the questionnaire or 3) 
had a reimplantation within 4 months. In addition, 
patients who were unable to complete the 
questionnaire (i.e., cognitive impairment or 
insufficient knowledge of the Dutch language) or 
were not being able to provide informed consent were 
not included into the study. When patients were 
eligible, one of the researchers (KV) approached them 
by phone explaining the purpose of this study and 
invited them to participate. We distributed an 
informative letter with a questionnaire to all patients 
by post to their home address. The questionnaire sets 
were sent and return between April and August 2017. 
All patients who gave written informed consent were 
able and willing to complete the questionnaire. 
Questionnaires 
The World Health Organization Quality of Life 
Brief Version (WHOQOL-BREF) measures QOL and 
contains 26 questions, divided into four domains and 
one facet. The domains consist of 1) Physical Health, 
2) Psychological health, 3) Social Relationships, and 4) 
Environment. In addition, two items form the facet 
Overall QOL and general health. Items are rated on 
5-point Likert scales. The mean score per domain 
ranges from 4 to 20. A higher scores indicate a better 
QOL (19).  
The EuroQoL 5 dimension 3 level version 
(EQ-5D-3L) questionnaire measures HS and 
comprises of two parts: the EQ-5D-3L self-classifier, a 
self-reported description of health problems 
according to a five-dimensional classification (i.e., 
mobility, self-care, usual activities, pain/discomfort 
and anxiety/depression) and is divided into 3 levels 
of perceived problems. Level 1 indicates no problems, 
level 2 indicates some problems and level 3 indicates 
extreme problems. The visual analogue scale (VAS) is 
designed to record the perceptions of a participant’s 
current overall health state. The scale is graduated 
from 0 (the worst imaginable health state) to 100 (the best 
imaginable state). In both, the time frame is the day of 
responding. An index (EQ Index) based on the five 
dimensions to describe the overall HS of these 
patients. The EQ-5D-3L and WHOQOL-BREF has 
good to excellent psychometric properties of 
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reliability (19-21). We used the Visual Analog Scale 
(VAS) for pain in rest and activity. Furthermore, the 
VAS for pain has acceptable psychometric properties 
(22). For the WHOQOL-BREF and EQ-5D-3L score 
Dutch norm scores and specified disease entities will 
be used to compare with our study population (20, 
23). 
Although HS and QOL are both patient-reported 
outcomes and multidimensional, the concepts differ. 
HS is merely an assessment of physical, psychological, 
and social functioning, whereas QOL focuses on the 
subjective evaluation of well-being in which the level 
of satisfaction is included (19, 24). 
Statistical analyses 
Descriptive analyses were performed to describe 
patient characteristics (i.e., age, gender, side, and 
duration of the Girdlestone situation). The 
Kolmogorov-Smirnov test was used to test the 
normality of study data. One sample T-tests were 
used to analyse whether the mean scores of the GRA 
group differs from the norm.  
We performed a subgroup analysis for age, 
gender, and duration for the effect on QOL and HS. 
The significance level used in the analyses was p<0.05. 
Data analyses were conducted using SPSS version 23.  
Results 
Patient cohort 
In total, 407 GRAs were recorded in the three 
participating hospitals; of these, in 206 patients a 
subsequent re-implantation was registered, of the 
remaining 201 cases, 65 died. In 32 cases, there was 
another indication than PJI for GRA. In 10 patients 
there was inability to complete the questionnaire due 
to dementia.  
Ninety-four patients with GRA after failed PJI 
treatment were eligible for this study. Thirty-nine 
patients did not have up-to-date contact information 
or were not willing to participate in the current study. 
Eight patients were added through the Dutch 
Girdlestone Patient Association. In total, 63 patients 
were included in this study (Figure 1), of which 27 
were males (43 %), the average age of patients was 
71.7 years (SD 12.1), the Girdlestone situation was 
right-sided in 57% of the patients, the infection was 
cured in 61 (97%) patients and the VAS score in rest 
and activity was 3.4 (SD=2.2) and 5.4 (SD=2.5) 
respectively (Table 1). The median time between the 
GRA and competing the questionnaire set was 48 (4 to 
436) months. There was one patient from the Dutch 
Girdlestone association who had had a Girdlestone 
situation for 436 months. We choose to include this 
patient because the study population is already 
scarce. 
 
Table 1. Patient characteristics of the study population (n = 63) 
 Mean (SD) or n (%) 
patients  
Age, years (SD) 71.8 (12.1) 
Male, n (%) 36 (57) 
Side, right, n (%) 36 (57) 
Mean VAS rest (SD)  3.4 (2.2) 
Mean VAS activity (SD)  5.4 (2.5) 
Median duration in months (minimum-maximum) 48 (4 - 436) 
Cure of infection, n (%) 61 (97) 
Abbreviations: VAS, visual analog scale, SD, standard deviation 
 
 
 
Figure 1. Flowchart showing inclusion/exclusion of the participants 
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Quality of life  
Means for the WHOQOL-BREF scores are 
presented in Table 2. Patients with a permanent 
situation after GRA scored significantly lower 
compared to the normative data in all domains 
(p<0.001). When comparing GRA with normative 
data, the domain scores were respectively 11.4 vs. 18.3 
for physical health, 12.9 vs. 16.6 for psychological 
health, 13.4 vs. 15.8 for social relationships and 13.1 
vs. 15.9 for environment. When comparing the scores 
of the GRA population with patients with a lower 
limb amputation or a myocardial infarction, the 
Girdlestone group scored worse. The subgroup 
analysis for age, gender and duration for the effect on 
QOL and HS did not show any significant correlation. 
 
Table 2. World Health Organization Quality of life 
(WHOQOL-BREF) facet and domain scores (range 4-20) 
compared with normative data and disease specific entities 
Facet/domains Girdlestone 
group 
Mean (SD) 
Dutch 
norm 
Values*1  
Difference in 
means (95% 
CI) 
P LLA*2 MI*3 
Overall QOL and 
General health 
11.3 (1.8) 14.2 (2.4) 2.9 (2.2, 3.8) <0.001 14.2 14.2 
Physical health  11.4 (2.0) 18.3 (3.0) 6.9 (6.2, 7.7) <0.001 13.0 13.1 
Psychological 
health 
12.9 (2.1) 16.6 (2.8) 3.8 (3.1, 4.5) <0.001 14.4 14.6 
Social 
relationships 
13.4 (2.8) 15.8 (3.3) 2.4 (1.6, 3.2) <0.001 14.0 15.4 
Environment 13.1 (2.2) 15.9 (2.8) 2.8 (2.1, 3.5) <0.001 15.6 14.2 
Scores for each domain ranges from 4 to 20. Higher scores denote higher quality of 
life.  
Abbreviations: MI, myocardial infarction, LLA, lower limb amputation, CI, 
confidence interval, SD, standard deviation.  
*1 (20), *2(16), *3(14) 
 
Table 3. Health status scores as assessed with the EQ-5D-3L 
domain compared to normative data and disease specific entities. 
Mean population EQ-VAS and mean EQ-5D-index. (n=63) 
Subscales Girdlestone 
group (SD) 
Normative 
data*(SD) 
Difference 
(95% CI) 
P-value LLA* MI* 
Mobility 2.1 (0.5) 1.2 (0.1) -0.95 (-0.95, 
-0.93) 
<0.001 1.5 1.6 
Self-care 2.0 (0.7) 1.0 (0.1) -0.96 (-0.99, 
-0.93) 
<0.001 1.8 1.2 
Usual activities 2.3 (0.7) 1.2 (0.1) 1.13 (-0.99, 
-0.93) 
<0.001 2.0 1.5 
Pain/discomfort 2.0 (0.6) 1.4 (0.2) 0.63 (-1.00, 
-0.92) 
<0.001 1.8 1.7 
Anxiety/depression  1.7 (0.7) 1.2 (0.1) 0.51 (0.48, 
0.55) 
<0.001 1.6 1.4 
EQ-VAS 52.4 (18.9) 82 (11.6) 29.60 (26.71 
-32.05) 
<0.001   
EQ-5D index  0.4 (0.3) 0.9 (0.1) 0.50 
(0.47-0.53) 
<0.001   
1= no problems, 2= some problems, 3= extreme problems, EQ-VAS (0-100), EQ-5D 
index (0-1). 
Abbreviations: MI, myocardial infarction, LLA, lower limb amputation, CI, 
confidence interval, SD, standard deviation.  
*(14, 17, 23) 
 
Health status  
GRA respondents scored significantly lower on 
all subscale scores of the EQ-5D-3L compared to data 
of the normal population (Table 3). Scores (a higher 
score means more problems in that specific subscale) 
were significantly different in the subscales of 
mobility (2.1 vs 1.2), self-care (2.0 vs 1.0), usual 
activities: (2.3 vs 1.2) pain/discomfort; 2.0 vs 1.4, 
anxiety/depression; 1.7 vs 1.2 (Table 3). These results 
show that HS is significantly impaired in GRA 
patients compared to normative data (p<0.001). Of the 
patients with GRA, 95.6% experienced problems in 
mobility, 77.8% in self-care, 91.1% in daily activities, 
84.5% had pain and discomfort, and 55.6% had 
symptoms of anxiety or depression. The average 
self-reported health scale (EQ-VAS) for GRA patients 
and normative data was respectively 52.4 (32.4 to 70.2) 
and 82 (70.4 to 93.6).  
Discussion  
In this study, we assessed HS and QOL in 
patients who underwent GRA after an infected total 
hip replacement. Patients with GRA after an infected 
total hip prosthesis have a reduced HS and QOL 
scores compared with the normal population and 
patients with lower limb amputation and myocardial 
infarction (14-17). QOL was significantly lower in all 
domains of both questionnaires. Even when 
comparing them with lower limb amputations and 
myocardial infarctions, it showed impaired results in 
all of them.  
Although GRA has proved to be a successful 
method for eradication of infection, it comes at a high 
expense due to the low functional outcome of the 
procedure. First, GRA leads to pseudo-artrosis with a 
leg length discrepancy, muscle weakness and a 
decreased range of motion (6-9, 11, 25, 26). 
Additionally, patients that undergo GRA are 
generally not deemed fit for a single- or two-stage 
revision of a total hip replacement due to their age 
and multiple comorbidities. As this patient group 
already has significant functional disabilities, a GRA 
procedure will undoubtedly lead to a critical situation 
that makes patients functionally dependent in their 
daily activities (8, 11, 27). As they are less ambulant 
which may result in a restricted freedom of 
maintaining the daily lifestyle, influencing their 
psychological wellbeing. It has been shown that a 
strong social network may relieve stress in crisis 
situations, as after a GRA. Social support may work as 
a protective factor and thus may increase QOL. 
Therefore, more emphasis on the expectation and 
social management of the postoperative situation 
could enhance the perceived QOL in this specific 
population (28, 29).  
Two previous studies that measured HS based 
on limited groups of patients provided inconclusive 
results using the short-form health survey to measure 
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HS (7, 12). Barbaric et al. retrospectively compared 53 
patients having a Girdlestone situation with 20 
patients who underwent revision arthroplasty. The 
average SF-36 physical component summary and 
mental component summary were respectively 27.7 
and 45.5, which is low. Yamamoto et al. 
retrospectively reported in 9 patients the SF-36 score 
with a unilateral Girdlestone situation. Measuring an 
overall health status of 75.4 which is a relatively high 
score (range 0-100). Thus, both studies where not in 
line with each other. The relatively high score in 
Yamamoto et al can be explained by the number of 
patients which is too low to draw firm conclusions. 
This study shows that patients have lower HS 
scores compared to the norm population with an 
EQ-5D-3L index score of 0.4. Similar to previous 
studies, the lowest scores were measured in 
functional subscales: mobility, usual activities, 
self-care, pain/discomfort (7, 12). The low EQ-VAS 
suggests low general health conditions of the included 
patients and corresponds to previous studies (10, 11). 
Helwig et al. collected data of patients with a 
prosthetic joint infection (hip or knee) and measured 
the overall QOL using the short form health survey 12 
(SF-12) and compare the successful treatment with the 
ongoing PJI. Their results showed that QOL is 
substantially reduced after a PJI when not treated 
successfully(30). This shows that already in the 
process from PJI to GRA the QOL is impaired. 
The high pain score observed in our study 
population was not in line with previous studies (6, 8, 
11) and questions the reported pain relief of GRA. In 
the previous studies pain was scored by other 
measurements than VAS pain score (6, 8-11, 25, 26, 
31). Therefore, the distinction in pain score can 
partially be explained by the differentiation between 
the rest and activity VAS pain score we were using. 
This study has included the highest number of 
patients with a permanent Girdlestone situation, with 
an average duration of 57.9 months for having a 
Girdlestone situation. Patients who are offered GRA 
were mainly elderly with an average age of 72 years, 
which is in line with other studies (7, 8, 26).  
When patients have a temporary Girdlestone 
situation, they will be getting a reimplantation in the 
near future (second-stage revision). Their perception 
on QOL may be more positive because of their future 
perspectives.  
As the patients that underwent GRA is a 
heterogeneous group, with different indication to 
undergo a GRA, various combinations of 
comorbidities, and a high age, it remains difficult to 
extrapolate the results to all patients that underwent a 
GRA (32). A combination of the functional evaluation 
and measuring patient-reported outcomes both 
pre-and postoperatively would truly measure the 
impact of a GRA on both objective and subjective 
scores. Information on comorbidities is lacking in this 
study, but could have a significant influence on the 
outcome of our study (11, 12, 33). Including patients 
through patient groups could introduce bias to our 
study population as they could have various reasons 
for encouragement to enroll into this study, for 
example due to dissatisfaction of their individual 
functional outcome.  
In conclusion, patients with a Girdlestone 
situation after an infected total hip prosthesis have a 
significantly impaired HS and QOL comparing to the 
normal population and other disease specific entities 
like lower limb amputation and myocardial 
infarction. They experience a high level of pain in rest 
and during activity. The importance of informing the 
patient on their postoperative status and the 
management of expectations needs to be underlined 
in a proper setting. We believe that this study offers 
valuable information when it comes to HS and QOL 
in patients after GRA. As the clinical situation after 
GRA highly restricts patients to functioning in daily 
activities, withholds the possibility to be part of a 
social network and greatly diminishes their 
psychological wellbeing, we stress the importance to 
aim to prevent a permanent Girdlestone situation and 
consider reimplantation if possible.  
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